Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Immunecare Biopharmaceuticals (shanghai) Co., Ltd.

Clinical trials sponsored by Immunecare Biopharmaceuticals (shanghai) Co., Ltd., explained in plain language.

Trials to join now! 2
Sort by
  • New injection shows promise for Hard-to-Treat lung condition

    Disease control Recruiting now

    This study tests an investigational drug called IMC-003 in 120 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work harder. Participants receive multiple injections of the drug or a placebo, alongside their usual treatments. The go…

    Phase: PHASE1, PHASE2 • Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control

    Last updated Jul 24, 2026 00:00 UTC

  • New drug aims to tame lupus flares

    Disease control Recruiting now

    This study tests an experimental drug called IMC-002 (also known as IMM0306) in people with active systemic lupus erythematosus (SLE), a chronic autoimmune disease. The trial compares the drug against a placebo, both given alongside standard care, to see if it can reduce disease …

    Phase: PHASE1, PHASE2 • Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control

    Last updated Jul 01, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space